SEARCH

SEARCH BY CITATION

References

  • Aarum J., Sandberg K., Haeberlein S. L. and Persson M. A. (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl Acad. Sci. USA, 100, 1598315988.
  • Abate W., Alghaithy A. A., Parton J., Jones K. P. and Jackson S. K. (2009) Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J. Lipid Res. 51, 334344.
  • Akira S., Uematsu S. and Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124, 783801.
  • Akiyama H., Arai T., Kondo H., Tanno E., Haga C. and Ikeda K. (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14(Suppl. 1), S47S53.
  • Anderson K. V., Bokla L. and Nusslein-Volhard C. (1985a) Establishment of dorsal–ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42, 791798.
  • Anderson K. V., Jurgens G. and Nusslein-Volhard C. (1985b) Establishment of dorsal–ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42, 779789.
  • Arbour N. C., Lorenz E., Schutte B. C., Zabner J., Kline J. N., Jones M., Frees K., Watt J. L. and Schwartz D. A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187191.
  • Balistreri C. R., Candore G., Listi F., Fazio T., Gangi S., Incalcaterra E., Caruso M., Vecchi M. L., Lio D. and Caruso C. (2007) Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging. Ann. N. Y. Acad. Sci. 1119, 203207.
  • Balistreri C. R., Colonna-Romano G., Lio D., Candore G. and Caruso C. (2009) TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol. 29, 406415.
  • Blanco A. M., Valles S. L., Pascual M. and Guerri C. (2005) Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175, 68936899.
  • Block M. L., Zecca L. and Hong J. S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 5769.
  • Blanco A. M., Perez-Arago A., Fernandez-Lizarbe S. and Guerri C. (2008) Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106, 625639.
  • Bowie A. and O’Neill L. A. (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67, 508514.
  • Cao C. X., Yang Q. W., Lv F. L., Cui J., Fu H. B. and Wang J. Z. (2007) Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353, 509514.
  • Caso J. R., Pradillo J. M., Hurtado O., Leza J. C., Moro M. A. and Lizasoain I. (2008) Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 39, 13141320.
  • Cao L., Palmer C. D., Malon J. T. and De Leo J. A. (2009) Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur. J. Immunol. 39, 35623569.
  • Caso J. R., Pradillo J. M., Hurtado O., Lorenzo P., Moro M. A. and Lizasoain I. (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115, 15991608.
  • Chakravarty S. and Herkenham M. (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25, 17881796.
  • DeLeo J. A., Rutkowski M. D., Stalder A. K. and Campbell I. L. (2000) Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport 11, 599602.
  • Department of Health and Human Services, N. I. o. H. (1998) New directions in pain research. Available from: http://grants.nih.gov/grants/guide/pa-files/PA-98-102.html
  • Fernandez-Lizarbe S., Pascual M., Gascon M. S., Blanco A. and Guerri C. (2008) Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol. Immunol. 45, 20072016.
  • Gangloff M., Weber A. N., Gibbard R. J. and Gay N. J. (2003) Evolutionary relationships, but functional differences, between the Drosophila and human Toll-like receptor families. Biochem. Soc. Trans. 31, 659663.
  • Glezer I., Lapointe A. and Rivest S. (2006) Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20, 750752.
  • Gradisar H., Keber M. M., Pristovsek P. and Jerala R. (2007) MD-2 as the target of curcumin in the inhibition of response to LPS. J. Leukoc. Biol. 82, 968974.
  • Hacker H., Redecke V., Blagoev B., et al. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204207.
  • Hashimoto C., Hudson K. L. and Anderson K. V. (1988) The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52, 269279.
  • Hickey E. J., You X., Kaimaktchiev V., Stenzel-Poore M. and Ungerleider R. M. (2007) Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 133, 15881596.
  • Horng T., Barton G. M., Flavell R. A. and Medzhitov R. (2002) The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329333.
  • Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K. and Akira S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 37493752.
  • Hua F., Ma J., Ha T., et al. (2007) Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190, 101111.
  • Hutchinson M. R., Bland S. T., Johnson K. W., Rice K. C., Maier S. F. and Watkins L. R. (2007) Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal 7, 98111.
  • Hutchinson M. R., Zhang Y., Brown K., et al. (2008) Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 2029.
  • Hutchinson M. R., Ramos K. M., Loram L. C., et al. (2009a) Evidence for a role of heat shock protein-90 (HSP90) in TLR4 mediated pain enhancement in rats. Neuroscience. 164, 18211832.
  • Hutchinson M. R., Zhang Y., Shridhar M., et al. (2009b) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 24, 8395.
  • Ii M., Matsunaga N., Hazeki K., Nakamura K., Takashima K., Seya T., Hazeki O., Kitazaki T. and Iizawa Y. (2006) A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69, 12881295.
  • Jou I., Lee J. H., Park S. Y., Yoon H. J., Joe E. H. and Park E. J. (2006) Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am. J. Pathol. 168, 16191630.
  • Juni A., Klein G., Pintar J. E. and Kest B. (2007) Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 147, 439444.
  • Kagan J. C. and Medzhitov R. (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943955.
  • Kagan J. C., Su T., Horng T., Chow A., Akira S. and Medzhitov R. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361368.
  • Kakimura J., Kitamura Y., Takata K., et al. (2002) Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 16, 601603.
  • Kawai T. and Akira S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460469.
  • Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G. and Mattson M. P. (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69, 273284.
  • Keller J. N., Hanni K. B. and Markesbery W. R. (1999) 4-Hydroxynonenal increases neuronal susceptibility to oxidative stress. J. Neurosci. Res. 58, 823830.
  • Kim H. M., Park B. S., Kim J. I., et al. (2007) Crystal structure of the TLR4–MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906917.
  • Kobayashi M., Saitoh S., Tanimura N., Takahashi K., Kawasaki K., Nishijima M., Fujimoto Y., Fukase K., Akashi-Takamura S. and Miyake K. (2006) Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176, 62116218.
  • Konat G. W., Krasowska-Zoladek A. and Kraszpulski M. (2008) Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation. J. Neurosci. Res. 86, 603609.
  • Lawson L. J., Perry V. H., Dri P. and Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151170.
  • Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J. and Vartanian T. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl Acad. Sci. USA 100, 85148519.
  • Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R. and Weber J. R. (2008) A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28, 23202331.
  • Liu B., Du L., Kong L. Y., Hudson P. M., Wilson B. C., Chang R. C., Abel H. H. and Hong J. S. (2000) Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97, 749756.
  • Liu H., Xin L., Chan B. P., Teoh R., Tang B. L. and Tan Y. H. (2002a) Interferon-beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci. Lett. 327, 146148.
  • Liu Y., Qin L., Wilson B. C., An L., Hong J. S. and Liu B. (2002b) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1–42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302, 12121219.
  • Maier S. F., Wiertelak E. P., Martin D. and Watkins L. R. (1993) Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res., 623, 321324.
  • Maier S. F. and Watkins L. R. (2003) Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain Behav. Immun. 17(Suppl 1), S125S131.
  • Marin-Teva J. L., Dusart I., Colin C., Gervais A., Van Rooijen N. and Mallat M. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41, 535547.
  • Marsh B., Stevens S. L., Packard A. E., Gopalan B., Hunter B., Leung P. Y., Harrington C. A. and Stenzel-Poore M. P. (2009) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 98399849.
  • Marta M., Meier U. C. and Lobell A. (2009) Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun. Rev. 8, 506509.
  • Marx J. (2004a) Cancer research. Inflammation and cancer: the link grows stronger. Science 306, 966968.
  • Marx J. (2004b) Pain research. Why other people may not feel your pain. Science 305, 328.
  • Mason P. (1993) Lipopolysaccharide induces fever and decreases tail flick latency in awake rats. Neurosci. Lett. 154, 134136.
  • Medzhitov R., Preston-Hurlburt P. and Janeway Jr C. A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394397.
  • Midwood K., Sacre S., Piccinini A. M., et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774780.
  • Milligan E. D. and Watkins L. R. (2009) Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10, 2326.
  • Minoretti P., Gazzaruso C., Vito C. D., Emanuele E., Bianchi M., Coen E., Reino M. and Geroldi D. (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer’s disease. Neurosci. Lett. 391, 147149.
  • Miyake K., Yamashita Y., Ogata M., Sudo T. and Kimoto M. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 33333340.
  • Nagai Y., Akashi S., Nagafuku M., et al. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667672.
  • Nobel Lectures (1965) Physiology or Medicine 1922–1941: Nobel Lectures, Including Presentation Speeches And Laureates’ Biographies. Elsevier Publishing Company, Amsterdam.
  • Ohnishi H., Tochio H., Kato Z., Orii K. E., Li A., Kimura T., Hiroaki H., Kondo N. and Shirakawa M. (2009) Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc. Natl Acad. Sci. USA 106, 1026010265.
  • Ohto U., Fukase K., Miyake K. and Satow Y. (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 16321634.
  • Okamura Y., Watari M., Jerud E. S., Young D. W., Ishizaka S. T., Rose J., Chow J. C. and Strauss III J. F. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 1022910233.
  • Pais T. F., Figueiredo C., Peixoto R., Braz M. H. and Chatterjee S. (2008) Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflamm. 5, 43.
  • Park B. S., Song D. H., Kim H. M., Choi B. S., Lee H. and Lee J. O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature 458, 11911195.
  • Poikonen K., Lajunen T., Silvennoinen-Kassinen S., Leinonen M. and Saikku P. (2009) Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro. Scand. J. Immunol. 70, 3439.
  • Poltorak A., He X., Smirnova I., et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 20852088.
  • Prohinar P., Re F., Widstrom R., Zhang D., Teghanemt A., Weiss J. P. and Gioannini T. L. (2007) Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J. Biol. Chem. 282, 10101017.
  • Rietschel E. T., Kirikae T., Schade F. U., et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217225.
  • Rittirsch D., Flierl M. A., Day D. E., et al. (2009) Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog. 5, e1000464.
  • Rosenzweig H. L., Lessov N. S., Henshall D. C., Minami M., Simon R. P. and Stenzel-Poore M. P. (2004) Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35, 25762581.
  • Rossignol D. P., Wasan K. M., Choo E., Yau E., Wong N., Rose J., Moran J. and Lynn M. (2004) Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers. Antimicrob. Agents Chemother. 48, 32333240.
  • Rowe D. C., McGettrick A. F., Latz E., et al. (2006) The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl Acad. Sci. USA 103, 62996304.
  • Sarnico I., Lanzillotta A., Benarese M., Alghisi M., Baiguera C., Battistin L., Spano P. and Pizzi M. (2009) NF-kappaB dimers in the regulation of neuronal survival. Int. Rev. Neurobiol. 85, 351362.
  • Schaefer L., Babelova A., Kiss E., et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 22232233.
  • Sha T., Sunamoto M., Kitazaki T., Sato J., Ii M. and Iizawa Y. (2007) Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur. J. Pharmacol. 571, 231239.
  • Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K. and Kimoto M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 17771782.
  • Slivka P. F., Shridhar M., Lee G. I., et al. (2009) A peptide antagonist of the TLR4-MD2 interaction. Chembiochem 10, 645649.
  • Smiley S. T., King J. A. and Hancock W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167, 28872894.
  • Stewart W. F., Kawas C., Corrada M. and Metter E. J. (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48, 626632.
  • Szabo G., Dolganiuc A., Dai Q. and Pruett S. B. (2007) TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects. J. Immunol. 178, 12431249.
  • Tahara K., Kim H. D., Jin J. J., Maxwell J. A., Li L. and Fukuchi K. (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 30063019.
  • Takashima K., Matsunaga N., Yoshimatsu M., Hazeki K., Kaisho T., Uekata M., Hazeki O., Akira S., Iizawa Y. and Ii M. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 12501262.
  • Tan L., Schedl P., Song H. J., Garza D. and Konsolaki M. (2008) The Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer’s Abeta42 polypeptide in Drosophila. PLoS One 3, e3966.
  • Tang S. C., Arumugam T. V., Xu X., et al. (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl Acad. Sci. USA 104, 1379813803.
  • Tang S. C., Lathia J. D., Selvaraj P. K., Jo D. G., Mughal M. R., Cheng A., Siler D. A., Markesbery W. R., Arumugam T. V. and Mattson M. P. (2008) Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 213, 114121.
  • Tanga F. Y., Nutile-McMenemy N. and DeLeo J. A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl Acad. Sci. USA 102, 58565861.
  • Tanimura N., Saitoh S., Matsumoto F., Akashi-Takamura S. and Miyake K. (2008) Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368, 9499.
  • Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H. and Hallenbeck J. M. (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267270.
  • Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C. and Simon J. C. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99111.
  • Triantafilou M. and Triantafilou K. (2004) Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem. Soc. Trans. 32, 636639.
  • Tsan M. F. and Gao B. (2004a) Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286, C739744.
  • Tsan M. F. and Gao B. (2004b) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514519.
  • Veldhuis W. B., Derksen J. W., Floris S., et al. (2003) Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J. Cereb. Blood Flow Metab. 23, 10291039.
  • Wakselman S., Bechade C., Roumier A., Bernard D., Triller A. and Bessis A. (2008) Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J. Neurosci. 28, 81388143.
  • Walter S., Letiembre M., Liu Y., et al. (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol. Biochem. 20, 947956.
  • Wang A. C., Su Q. B., Wu F. X., Zhang X. L. and Liu P. S. (2009) Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur. J. Clin. Invest. 39, 157164.
  • Watkins L. R. and Maier S. F. (1999) Implications of immune-to-brain communication for sickness and pain. Proc. Natl Acad. Sci. USA 96, 77107713.
  • Weatherill A. R., Lee J. Y., Zhao L., Lemay D. G., Youn H. S. and Hwang D. H. (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 53905397.
  • Wong S. W., Kwon M. J., Choi A. M., Kim H. P., Nakahira K. and Hwang D. (2009) Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a ros-dependent manner. J. Biol. Chem. 284, 2738427392.
  • Wu H. E., Sun H. S., Cheng C. W., Terashvili M. and Tseng L. F. (2006) dextro-Naloxone or levo-naloxone reverses the attenuation of morphine antinociception induced by lipopolysaccharide in the mouse spinal cord via a non-opioid mechanism. Eur. J. Neurosci. 24, 25752580.
  • Yamamoto M., Sato S., Hemmi H., et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640643.
  • Yamada M., Ichikawa T., Ii M., Sunamoto M., Itoh K., Tamura N. and Kitazaki T. (2005) Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate. J. Med. Chem. 48, 74577467.
  • Youn H. S., Lee J. Y., Fitzgerald K. A., Young H. A., Akira S. and Hwang D. H. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 33393346.
  • Youn H. S., Saitoh S. I., Miyake K. and Hwang D. H. (2006) Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72, 6269.
  • Youn H. S., Lee J. K., Choi Y. J., Saitoh S. I., Miyake K., Hwang D. H. and Lee J. Y. (2008) Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem. Pharmacol. 75, 494502.
  • Younger J. and Mackey S. (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 10, 663672.
  • Younger J. W., Zautra A. J. and Cummins E. T. (2009) Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS One 4, e5180.
  • Yusuf N., Nasti T. H., Meleth S. and Elmets C. A. (2009) Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol. Carcinog. 48, 713723.
  • Zhao W., Beers D. R., Henkel J. S., Zhang W., Urushitani M., Julien J. P. and Appel S. H. (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231243.
  • Zhou H., Lapointe B. M., Clark S. R., Zbytnuik L. and Kubes P. (2006) A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 177, 81038110.
  • Zimmer S. M., Liu J., Clayton J. L., Stephens D. S. and Snyder J. P. (2008) Paclitaxel binding to human and murine MD-2. J. Biol. Chem. 283, 2791627926.